MicroRNA Regulators of Anxiety and Metabolic Disorders

Trends Mol Med. 2016 Sep;22(9):798-812. doi: 10.1016/j.molmed.2016.07.001. Epub 2016 Aug 3.

Abstract

Anxiety-related and metabolic disorders are under intense research focus. Anxiety-induced microRNAs (miRNAs) are emerging as regulators that are not only capable of suppressing inflammation but can also induce metabolic syndrome-related processes. We summarize here evidence linking miRNA pathways which share regulatory networks in metabolic and anxiety-related conditions. In particular, miRNAs involved in these disorders include regulators of acetylcholine signaling in the nervous system and their accompanying molecular machinery. These have been associated with anxiety-prone states in individuals, while also acting as inflammatory suppressors. In peripheral tissues, altered miRNA pathways can lead to dysregulated metabolism. Common pathways in metabolic and anxiety-related phenomena might offer an opportunity to reclassify 'healthy' and 'unhealthy', as well as metabolic and anxiety-prone biological states, and inform putative strategies to treat these disorders.

Keywords: anxiety; cholinergic; metabolic disorder; miRNAs; obesity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / genetics
  • Acetylcholine / metabolism
  • Animals
  • Anxiety / complications*
  • Anxiety / genetics*
  • Anxiety / metabolism
  • Gene Expression Regulation
  • Humans
  • Inflammation / complications
  • Inflammation / genetics
  • Inflammation / metabolism
  • Metabolic Diseases / complications*
  • Metabolic Diseases / genetics*
  • Metabolic Diseases / metabolism
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Signal Transduction

Substances

  • MicroRNAs
  • Acetylcholine